Pharmaceutical

Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline

Novo Nordisk will pay up to $1.1bn in upfront and milestone-based payments, with the acquisition expected to close in Q2 2024.

Mar 26, 2024 - 00:00
Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline
Novo Nordisk will pay up to $1.1bn in upfront and milestone-based payments, with the acquisition expected to close in Q2 2024.
Read the original article

Tags:

Previous Article

Pharmaceutical packaging companies and labelling machines

Next Article

Elahere secures full approval from FDA for types of ovarian cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Drug shortages challenge type 2 diabetes patients in the UK

Drug shortages challenge type 2 diabetes patients in th...

Jan 27, 2024

Who’s hiring who? Hiring activity in the Asia-Pacific pharma industry increased by 2% in Q1 2023

Who’s hiring who? Hiring activity in the Asia-Pacific p...

Jun 9, 2023

STAT+: Once bullish on digital health, Orexo hits a wall on reimbursement

STAT+: Once bullish on digital health, Orexo hits a wal...

Apr 29, 2023